Jacobson Pharma Dividend
Dividend criteriumcontroles 4/6
Jacobson Pharma is a dividend paying company with a current yield of 8.59% that is well covered by earnings.
Belangrijke informatie
8.6%
Dividendrendement
-2.5%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 6.1% |
| Toekomstig dividendrendement | n/a |
| Dividendgroei | 21.9% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | HK$0.055 |
| Uitbetalingsratio | 57% |
Recente dividendupdates
Recent updates
Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now
Aug 21
Jacobson Pharma's (HKG:2633) Profits May Not Reveal Underlying Issues
Dec 21Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025
Nov 27These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well
Jun 20Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's
Nov 28Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.0268
Sep 25Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?
Sep 16Jacobson Pharma's (HKG:2633) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 28Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's
Jul 14Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?
Feb 09Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.012
Nov 29Jacobson Pharma (HKG:2633) Is Reducing Its Dividend To HK$0.015
Sep 24Here's Why It's Unlikely That Jacobson Pharma Corporation Limited's (HKG:2633) CEO Will See A Pay Rise This Year
Sep 16Kwing Tong Lam Is The Independent Non-Executive Director of Jacobson Pharma Corporation Limited (HKG:2633) And They Just Picked Up 28% More Shares
Feb 03
A Look At The Fair Value Of Jacobson Pharma Corporation Limited (HKG:2633)
Jan 24Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden
Jan 11Does Jacobson Pharma's (HKG:2633) CEO Salary Compare Well With The Performance Of The Company?
Dec 27Is It Smart To Buy Jacobson Pharma Corporation Limited (HKG:2633) Before It Goes Ex-Dividend?
Dec 12Reflecting on Jacobson Pharma's (HKG:2633) Share Price Returns Over The Last Three Years
Dec 03Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: 2633 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Groeiend dividend: 2633's dividend payments have increased, but the company has only paid a dividend for 8 years.
Dividendrendement versus markt
| Jacobson Pharma Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (2633) | 8.6% |
| Markt onderkant 25% (HK) | 3.2% |
| Markt Top 25% (HK) | 7.9% |
| Gemiddelde industrie (Pharmaceuticals) | 3.7% |
| Analist prognose (2633) (tot 3 jaar) | n/a |
Opmerkelijk dividend: 2633's dividend (8.59%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.25%).
Hoog dividend: 2633's dividend (8.59%) is in the top 25% of dividend payers in the Hong Kong market (7.92%)
Winstuitkering aan aandeelhouders
Verdiendekking: With its reasonable payout ratio (56.7%), 2633's dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: With its reasonably low cash payout ratio (30.7%), 2633's dividend payments are well covered by cash flows.